Glenmark Pharmaceuticals gets final approval for Potassium Chloride Extended-Release Capsules USP, 10 mEq

From USFDA

Glenmark Pharmaceuticals announced that it has secured final approval from United States Food & Drug Administration (US FDA) for Potassium Chloride Extended-Release Capsules USP, 10 mEq, the therapeutic equivalent to the reference listed drug product, Potassium Chloride Extended- Release Capsules USP, 10 mEq, of Actavis Laboratories FL, Inc.

Powered by Capital Market - Live News